Knockdown of HM13 Inhibits Metastasis, Proliferation, and M2 Macrophage Polarization of Non-small Cell Lung Cancer Cells by Suppressing the JAK2/STAT3 Signaling Pathway
Applied Biochemistry and Biotechnology · 2025
DOI: 10.1007/s12010-024-05054-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, 2025. Verfasst von Dashu Xiao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Chaohu Hospital of Anhui Medical University, Chaohu, 238000, Anhui, China. Hauptthemen laut MEDLINE: Janus Kinase 2, STAT3 Transcription Factor, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Anhui Medical University.
Abstract (Originalsprache)
An upregulated histocompatibility minor 13 (HM13) has been studied in various tumors, yet the exact mechanism of HM13 in non-small cell lung cancer (NSCLC) is unclear. In view of same, the present study investigates crucial role and action mechanism of HM13 in human NSCLC. HM13 expression was higher in NSCLC tissue and cells through the Western blotting technique along with qRT-PCR. As per data from The Cancer Genome Atlas (TCGA), NSCLC patients having high HM13 expression show lower overall survival. 5-ethynyl-2-deoxyuridine (EdU), Cell Counting Kit-8 (CCK-8), and transwell tests were assessed for NSCLC cell growth, and invasion, and we found that silencing of HM13 inhibited the NSCLC cell proliferation, invasion. Additionally, to investigate the effects of HM13 on THP-1 macrophage polarization, a co-culture model of NSCLC and THP-1 macrophages were used. The CD206 + macrophages were examined using flow cytometry. As the markers of M2 macrophage, the mRNA levels of IL-10 and TGF-β of THP-1 cells were also detected by qRT-PCR. Knockdown of HM13 could inhibit the M2 polarization. Further experiments demonstrated that downregulated HM13 could inhibit the JAK2/STAT3 signaling pathway. RO8191 (activator of JAK/STAT3 pathway) influenced the invasion, proliferation, and expression of JAK2/STAT3 signaling pathway and Epithelial-mesenchymal transition (EMT) markers induced by HM13 silencing. HM13 knockdown also inhibited the tumor growth in vivo by xenograft nude mouse model. By inhibiting JAK2/STAT3 signaling pathway, HM13 knockdown inhibited the NSCLC cell proliferation, metastasis tumor growth, and tumor-associated macrophage M2 polarization. In NSCLC, HM13 could be a therapeutic target to treat the NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Chaohu Hospital of Anhui Medical University, Chaohu, 238000, Anhui, China.
- Department of Respiratory Medicine, Chaohu Hospital of Anhui Medical University, Chaohu, 238000, Anhui, China.
- Department of Oncology, Chaohu Hospital of Anhui Medical University, No. 64 Chaohu North Road, Juchao District, Chaohu, 238000, Anhui, China. xiaoxin20201009@163.com.
Förderung
- Anhui Medical University
Zitieren
APA
Xiao, D., Zhu, H., & Xiao, X. (2025). Knockdown of HM13 Inhibits Metastasis, Proliferation, and M2 Macrophage Polarization of Non-small Cell Lung Cancer Cells by Suppressing the JAK2/STAT3 Signaling Pathway. Applied Biochemistry and Biotechnology. https://doi.org/10.1007/s12010-024-05054-7
Vancouver
Xiao D, Zhu H, Xiao X. Knockdown of HM13 Inhibits Metastasis, Proliferation, and M2 Macrophage Polarization of Non-small Cell Lung Cancer Cells by Suppressing the JAK2/STAT3 Signaling Pathway. Applied Biochemistry and Biotechnology. 2025. doi:10.1007/s12010-024-05054-7
BibTeX
@article{Xiao2025,
author = {Xiao, Dashu and Zhu, Hongbin and Xiao, Xin},
title = {Knockdown of HM13 Inhibits Metastasis, Proliferation, and M2 Macrophage Polarization of Non-small Cell Lung Cancer Cells by Suppressing the JAK2/STAT3 Signaling Pathway},
journal = {Applied Biochemistry and Biotechnology},
year = {2025},
doi = {10.1007/s12010-024-05054-7}
}
EUVIMED